Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Endometriosis Market Size Shifted, And What Is the Outlook Through 2034?
In the past few years, the endometriosis market has witnessed robust growth. The market which is estimated to be $1.4 billion in 2024 is predicted to rise to $1.54 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%. The growth experienced during the historic period is the result of delayed diagnosis and improved awareness, advancements in laparoscopic surgery, hormonal therapies, and the role of patient advocacy and support groups.
In the coming years, the endometriosis market size is predicted to witness robust growth. It is projected to reach$2.21 billion in 2029, expanding at a compound annual growth rate (CAGR) of 9.4%. The escalating growth in the forecasted period can be accredited to the advancements in minimally invasive procedures, pharmaceutical innovations, and research in genetics and epigenetics, as well as the global enlargement of women’s healthcare. Key trends expected to dominate during the forecast period comprise patient-focused care, precision medicine, virtual healthcare, and telemedicine, as well as fertility preservation.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13035&type=smp
What Are the Core Growth Drivers Propelling the Endometriosis Market Forward?
The escalating occurrence of ovarian cancer is predicted to stimulate the expansion of the endometriosis market. Ovarian cancer originates in the ovaries, the female organs that generate eggs and hormones like estrogen and progesterone. Endometriosis heightens the risk of epithelial ovarian cancer, particularly the endometrioid and precise cell cancer subtypes, which are recognized by elevated levels of estrogen that amplify the chances of ovarian cancer. For example, the American Cancer Society, a professional organization based in the US, forecasted in January 2023 that around 19,710 new ovarian cancer cases will be identified among women in the US in 2023. In addition, the Ovarian Cancer Research Alliance, an American non-profit organization, reported in 2022 that ovarian cancer was responsible for 12,810 death in 2022, which rose to 13,270 fatalities in 2023. Consequently, the rising occurrence of ovarian cancer is fueling the progression of the endometriosis market.
What Segment Types Define the Endometriosis Market Structure?
The endometriosismarket covered in this report is segmented –
1) By Type: Superficial Peritoneal Lesion; Endometrioma; Deeply Infiltrating Endometriosis; Other Types
2) By Treatment Type: Hormonal Therapy; Pain Management
3) By Drug: Oral Contraceptives; Progestins; Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Gonadotropin Releasing Hormone (GnRH) Analogues; Levonorgestrel-Releasing Intrauterine Devices (LNR-IUDs); Other Drugs
4) By End-User: Hospitals; Homecare; Specialty Centers; Other End-Users
Subsegments:
1) By Superficial Peritoneal Lesion: Endometriotic Nodules; Peritoneal Endometriosis
2) By Endometrioma: Chocolate Cysts
3) By Deeply Infiltrating Endometriosis: Bowel Endometriosis; Ureteral Endometriosis; Vaginal Endometriosis
4) By Other Types: Abdominal Endometriosis; Thoracic Endometriosis
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13035&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Endometriosis Market?
North America was the largest region in the endometriosis market in 2024. The regions covered in endometriosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Which Emerging Trends that Are Influencing theEndometriosis Industry Evolution?
Leading companies in the endometriosis market are striving to develop innovative medications like Myfembree and secure approvals to offer new treatment alternatives for patients. The emergence of groundbreaking drugs for endometriosis caters to a formerly unaddressed need for successful therapies. For instance, in August 2022, Myovant Sciences GmbH, a biopharmaceutical firm based in Switzerland, and Pfizer Inc., an American pharmaceutical company, acquired U.S. FDA approval for Myfembree. This drug has been approved for managing moderate to severe pain linked with endometriosis in premenopausal women. Myfembree is a daily pill that merges three vital components: relugolix, estradiol, and norethindrone acetate, and offers confirmed relief for premenopausal women, covering two indications in one pill. This opens up an alternative therapy route for women who’re unable or favor not to employ hormone therapy.
View the full report here:
https://www.thebusinessresearchcompany.com/report/endometriosis-global-market-report
What Is the Definition of the Endometriosis Market?
Endometriosis is a chronic medical condition that occurs when tissue similar to the lining of the uterus (endometrium) grows outside the uterus. The condition can cause severe pain in the pelvis and make it harder to get pregnant. It can significantly impact a person’s quality of life and fertility.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13035
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model